$20mm not coming in until 1st patient dosed,but could get PR @ any time once PFE gets P3 up/running and begins recruitment! Guidance for trial start is 'mid year'. Agree completely with you about foolishness of 'technical' sellers here as the stock has dipped below $8. As I noted given the chart the sellers/shorts are being drawn in hoping for a technical retrace to $7 and that target could be reversed in an instant if/when volume comes in on buy side above $8 again. Get through high $8s and she's off to the races in the teens. 'da boyz may be playing with technical shorts and also accumulating shares ahead of PFE announcement.
Low $7s before teens unfortunately, as today's trade broke the neckline of a H &S that targets $7.30s.Obviously TA is unpredictable with low floaters like glyc,however, I have no intention of adding before 730s.
Slide 34=GS-4774 data listed as 2015 significant milestone/event. GS-9620 data no longer listed as a 2015 event. Seems as though GILD may be prepping to highlight Globe Immune's 4774 P2 data and has backed off on late April guidance indicating that their proprietary P2 candidate 9620's data would also read out in 2015.
Guidance=GS-4774 w/b available to GBIM in 1st 1/2.Irrespective of GILD's decision to present the full data set later in year one would think that receipt of any 4774 by GBIM w/b 'material' for the company and require publicly reporting at least top line.Expect some level of data out w/i coming 45 days.
Also company gave no indication of need/desire to Finance ahead of this data.They have $13mm+,ramped burn down and say the runway is to mid '16.
$35mm+ market cap net of cash has some very good risk reward here.Downside is cash + value of chordoma & celg deal=$3? while upside is $20++ with GS-4774 sero-conversion,P2b or P3 advancement...
Volume good,but not yet great.Need to close above $8.54 resistance and then the all important $9 level to have a major break out with initial targets in the $15 area.
agree completely. NEA alone owns 50.3%!
Get the Riv P3 up and running next month and the addt'l $20mm($1 per share more of cash) in the bank and that alone should increase market cap markedly as
ditto that on all points Hale.I hope the long suffering SHs here make a boat load of money. i continue to watch from a distance and almost pulled the trigger again on the
thankyou.I'm optimistic that CSeries will find some orders next month in Paris or soon thereafter.There is so much bad news in stock that once the turnaround effort gains traction the stock will respond very favorably.Last week's volume spike Thursday suggests institutions liked the 1st steps laid out by new team. btw, the rail ipo w/b very well received.look at the multiples in the rail industry generally and the relatively stable growth prospects.I suspect we'll see a deal with GE,Chinese Rail,etc for a minority stake prior to ipo which will drive value further.